Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Remote Ischemic Conditioning on 2,3-bisphosphoglycerate in Erythrocyte

NCT04192578 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT04192578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04192578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Remote Ischemic Conditioning on 2,3-bisphosphoglycerate in Erythrocyte
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2021
Completion date
March 15, 2021
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

2,3-bisphosphoglycerate